We have previously found that CFS/ME patients exhibit significantly upregulated expression of EBI2 in PBMC as compared with normal controls, in gene expression arrays and reverse-transcriptase polymerase chain reaction (RT-PCR) confirmation assays (90). This evidence concerns the gene GPR183 and myalgic encephalomeyelitis/chronic fatigue syndrome.